Location: Jefferson City

120 Hospital Dr

Suite 260

Jefferson City, Tennessee 37760

Tel: (423) 212-5593

Fax: (423) 212-5594

Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS)

Location(s): Jefferson City

Condition: Heart / Cardiovascular Disease